| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9402372 | Journal of Surgical Research | 2005 | 7 Pages |
Abstract
TRD does not impair the liver tissue, kidneys, SVC, and leucopoiesis. The intravenous therapy of 2% TRD is safe and anti-tumorigenic in advanced local tumor growth in rats.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Chris M.D., Benedikt Stuhldreier, Eva Bobrich, Charalambos M.D., Stephan Rogalla, Christoph A. M.D., Ph.D,